Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2646
Source ID: NCT02298192
Associated Drug: Insulin Degludec/Liraglutide
Title: A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
Acronym: DUAL™ VI
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT02298192/results
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: insulin degludec/liraglutide
Outcome Measures: Primary: Change From Baseline in HbA1c, Change in glycosylated haemoglobin A1c (HbA1c) (%) from baseline after 32 weeks of treatment., Week 0, week 32 | Secondary: HbA1c Below 7.0%, Responders to HbA1c below 7% after 32 weeks of treatment., Week 0, week 32|HbA1c Below or Equal to 6.5%, Responders to HbA1c below or equal to 6.5% after 32 weeks of treatment., Week 0, week 32|Number of Treatment Emergent Severe or Blood Glucose (BG) Confirmed Symptomatic Hypoglycaemic Episodes, An episode that is severe according to the ADA classification or BG confirmed by a plasma glucose value \<3.1 mmol/L (56 mg/dL) with symptoms consistent with hypoglycaemia., Week 0-32
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 420
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2014-11-21
Completion Date: 2015-12-23
Results First Posted: 2017-05-23
Last Update Posted: 2017-05-23
Locations: Novo Nordisk Investigational Site, Hamilton, Alabama, 35570, United States|Novo Nordisk Investigational Site, Chandler, Arizona, 85224, United States|Novo Nordisk Investigational Site, Glendale, Arizona, 85306-4652, United States|Novo Nordisk Investigational Site, Glendale, Arizona, 85308, United States|Novo Nordisk Investigational Site, Mesa, Arizona, 85213, United States|Novo Nordisk Investigational Site, Phoenix, Arizona, 85018, United States|Novo Nordisk Investigational Site, Phoenix, Arizona, 85020, United States|Novo Nordisk Investigational Site, Tucson, Arizona, 85741, United States|Novo Nordisk Investigational Site, Anaheim, California, 92801, United States|Novo Nordisk Investigational Site, Palm Springs, California, 92262, United States|Novo Nordisk Investigational Site, Walnut Creek, California, 94598, United States|Novo Nordisk Investigational Site, Colorado Springs, Colorado, 80904, United States|Novo Nordisk Investigational Site, Boynton Beach, Florida, 33472, United States|Novo Nordisk Investigational Site, Clearwater, Florida, 33765, United States|Novo Nordisk Investigational Site, Hallandale Beach, Florida, 33009, United States|Novo Nordisk Investigational Site, Miami, Florida, 33173, United States|Novo Nordisk Investigational Site, Orlando, Florida, 32801, United States|Novo Nordisk Investigational Site, Tampa, Florida, 33603, United States|Novo Nordisk Investigational Site, Conyers, Georgia, 30094-5965, United States|Novo Nordisk Investigational Site, Blackfoot, Idaho, 83221, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60607, United States|Novo Nordisk Investigational Site, Indianapolis, Indiana, 46254, United States|Novo Nordisk Investigational Site, Crestview Hills, Kentucky, 41017-3464, United States|Novo Nordisk Investigational Site, Troy, Michigan, 48098, United States|Novo Nordisk Investigational Site, Las Vegas, Nevada, 89103, United States|Novo Nordisk Investigational Site, Nashua, New Hampshire, 03063, United States|Novo Nordisk Investigational Site, West Seneca, New York, 14224, United States|Novo Nordisk Investigational Site, Greensboro, North Carolina, 27408, United States|Novo Nordisk Investigational Site, Norman, Oklahoma, 73069, United States|Novo Nordisk Investigational Site, Philadelphia, Pennsylvania, 19107, United States|Novo Nordisk Investigational Site, Greer, South Carolina, 29651, United States|Novo Nordisk Investigational Site, Spartanburg, South Carolina, 29303, United States|Novo Nordisk Investigational Site, Humboldt, Tennessee, 38343, United States|Novo Nordisk Investigational Site, Kingsport, Tennessee, 37660, United States|Novo Nordisk Investigational Site, Houston, Texas, 77008, United States|Novo Nordisk Investigational Site, Katy, Texas, 77450, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78215, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78240, United States|Novo Nordisk Investigational Site, Newport News, Virginia, 23606, United States|Novo Nordisk Investigational Site, Richmond, Virginia, 23294, United States|Novo Nordisk Investigational Site, Linz, 4021, Austria|Novo Nordisk Investigational Site, Mödling, 2340, Austria|Novo Nordisk Investigational Site, St. Stefan, 8511, Austria|Novo Nordisk Investigational Site, Wien, 1010, Austria|Novo Nordisk Investigational Site, Wien, 1090, Austria|Novo Nordisk Investigational Site, Wien, 1130, Austria|Novo Nordisk Investigational Site, Wien, 1230, Austria|Novo Nordisk Investigational Site, Kozloduy, 3320, Bulgaria|Novo Nordisk Investigational Site, Lukovit, 5770, Bulgaria|Novo Nordisk Investigational Site, Ruse, 7000, Bulgaria|Novo Nordisk Investigational Site, Sofia, 1784, Bulgaria|Novo Nordisk Investigational Site, Varna, 9002, Bulgaria|Novo Nordisk Investigational Site, Burnaby, British Columbia, V5G 1T4, Canada|Novo Nordisk Investigational Site, Coquitlam, British Columbia, V3K 3P4, Canada|Novo Nordisk Investigational Site, Surrey, British Columbia, V3S 2N6, Canada|Novo Nordisk Investigational Site, Moncton, New Brunswick, E1G 1A7, Canada|Novo Nordisk Investigational Site, Halifax, Nova Scotia, B3K 2M5, Canada|Novo Nordisk Investigational Site, Liverpool, Nova Scotia, B0T 1K0, Canada|Novo Nordisk Investigational Site, London, Ontario, N6G 2M1, Canada|Novo Nordisk Investigational Site, Waterloo, Ontario, N2J 1C4, Canada|Novo Nordisk Investigational Site, Olomouc, Lazce, 77900, Czechia|Novo Nordisk Investigational Site, Plzen, 30166, Czechia|Novo Nordisk Investigational Site, Plzen, 32600, Czechia|Novo Nordisk Investigational Site, Praha 4, 140 46, Czechia|Novo Nordisk Investigational Site, Trutnov, 541 01, Czechia|Novo Nordisk Investigational Site, Budapest, 1089, Hungary|Novo Nordisk Investigational Site, Budapest, 1135, Hungary|Novo Nordisk Investigational Site, Debrecen, 4043, Hungary|Novo Nordisk Investigational Site, Szombathely, H-9700, Hungary|Novo Nordisk Investigational Site, Zalaegerszeg, 8900, Hungary|Novo Nordisk Investigational Site, Barnaul, 656024, Russian Federation|Novo Nordisk Investigational Site, Barnaul, 656045, Russian Federation|Novo Nordisk Investigational Site, Cheboksary, 428000, Russian Federation|Novo Nordisk Investigational Site, Saint-Petersburg, 194358, Russian Federation|Novo Nordisk Investigational Site, Samara, 443041, Russian Federation|Novo Nordisk Investigational Site, St. Petersburg, 194354, Russian Federation|Novo Nordisk Investigational Site, Belgrade, 11000, Serbia|Novo Nordisk Investigational Site, Bratislava, 81108, Slovakia|Novo Nordisk Investigational Site, Bratislava, 82102, Slovakia|Novo Nordisk Investigational Site, Bratislava, 851 01, Slovakia|Novo Nordisk Investigational Site, Dunajska Streda, 92901, Slovakia|Novo Nordisk Investigational Site, Sabinov, 08301, Slovakia|Novo Nordisk Investigational Site, Vranov nad Toplou, 09301, Slovakia|Novo Nordisk Investigational Site, Zilina, 01207, Slovakia
URL: https://clinicaltrials.gov/show/NCT02298192

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress